Methallylescaline
![]() | |
| Names | |
|---|---|
| IUPAC name
2-{3,5-dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}ethanamine | |
| Identifiers | |
| 207740-41-8 | |
| ChEMBL | ChEMBL126803 |
| ChemSpider | 21106346 |
| Jmol 3D model | Interactive image |
| |
| |
| Properties | |
| C14H21NO3 | |
| Molar mass | 251.321 g/mol |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| | |
| Infobox references | |
Methallylescaline, or 4-methallyloxy-3,5-dimethoxyphenethylamine, is a lesser-known psychedelic drug. It is also the 4-methyl analog of allylescaline. Methallylescaline was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 40–65 mg, and the duration listed as 12–16 hours. Methallylescaline produces intense open and closed-eye visuals, such as neon colors and kaleidoscope-like imagery. Very little data exists about the pharmacological properties, metabolism, and toxicity of methallylescaline.
Legal status
Allylescaline is illegal in Sweden as of 26 January 2016.[1]
See also
References
- ↑ "31 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. November 2015.
External links
| ||||||||||||||||||||||||||||||||||
| ||||||
This article is issued from Wikipedia - version of the Wednesday, May 04, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
